CV SCIENCES, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0499 USD | -5.85% |
|
+1.84% | +40.96% |
| May. 14 | Transcript : CV Sciences, Inc., Q1 2024 Earnings Call, May 14, 2024 | |
| Mar. 28 | Transcript : CV Sciences, Inc., Q4 2023 Earnings Call, Mar 28, 2024 |
Presentation Operator MessageOperator (Operator)Good afternoon, and welcome to CV Sciences Fou...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
CV Sciences, Inc. is a consumer wellness company specializing in nutraceuticals and plant-based foods. Its hemp extracts, and other science-backed, natural ingredients and products are sold through a range of sales channels from business-to-business to business-to-consumer. It operates a drug development program focused on developing and commercializing cannabidiol (CBD)-based therapeutics. It develops, manufactures, markets and sells herbal supplements, CBD products and plant-based food products under brands: +PlusCBD and Cultured Foods in the healthcare market sector: nutraceutical, beauty care, specialty foods, and pet products. +PlusCBD branded products are sold at select retail locations throughout the United States. Cultured Foods brand provides a variety of plant-based food products and caters to individuals seeking vegan, gluten-free, or flexitarian options for a culinary experience. It manufactures encapsulated softgels and tinctures for the supplement and nutrition industry.
Sector
Pharmaceuticals
Calendar
2024-06-03
- Annual General Meeting
| 1st Jan change | Capi. | |
|---|---|---|
| +40.96% | 8.65M | |
| +31.37% | 588B | |
| -2.60% | 364B | |
| +20.83% | 326B | |
| +5.69% | 285B | |
| +14.83% | 239B | |
| +9.93% | 210B | |
| -6.95% | 200B | |
| +10.77% | 167B | |
| +0.10% | 161B |
- Stock Market
- Equities
- CVSI Stock
- News CV Sciences, Inc.
- Transcript : CV Sciences, Inc., Q4 2020 Earnings Call, Mar 18, 2021
